Advertisement

Topics

Many chronic urticaria patients are not receiving treatment, Novartis study shows

07:37 EDT 20 Jun 2017 | News-Medical.net

Novartis announced today new baseline results from a real world study of 3,733 chronic urticaria (CU) patients showing many are not receiving adequate care, with almost half (42%) not receiving any treatment at all for the debilitating disease despite 83% suffering a negative impact on their quality of life.

Original Article: Many chronic urticaria patients are not receiving treatment, Novartis study shows

NEXT ARTICLE

More From BioPortfolio on "Many chronic urticaria patients are not receiving treatment, Novartis study shows"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...